Clinical Trial Update: Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Azimilide for prophylaxis of atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Azimilide (azimilide)

Snippet

Sponsor: Forest Laboratories | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED